IDH1-mutated gliomas rely on anaplerosis of glutamate and lactate whereas IDH1 wild-type gliomas rely on glycolysis and acetate anaplerosis

被引:1
|
作者
Khurshed, Mohammed
Lenting, Krissie
Molenaar, Remco J.
Leenders, William P.
van Noorden, Cornelis J.
机构
关键词
D O I
10.1158/1538-7445.AM2017-431
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
431
引用
收藏
页数:2
相关论文
共 50 条
  • [1] IDH1-mutated gliomas rely on anaplerosis of glutamate and lactate whereas IDH1 wild-type gliomas rely on glycolysis and acetate anaplerosis
    Khurshed, Mohammed
    Lenting, Krissie
    Peeters, Tom
    Molenaar, Remco J.
    Leenders, William
    van Noorden, Cornelis
    FASEB JOURNAL, 2018, 32 (01):
  • [2] In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
    Khurshed, Mohammed
    Molenaar, Remco J.
    Lenting, Krissie
    Leenders, William P.
    van Noorden, Cornelis J. F.
    ONCOTARGET, 2017, 8 (30) : 49165 - 49177
  • [3] Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas
    Jin, Genglin
    Reitman, Zachary J.
    Duncan, Christopher G.
    Spasojevic, Ivan
    Gooden, David M.
    Rasheed, B. Ahmed
    Yang, Rui
    Lopez, Giselle Y.
    He, Yiping
    McLendon, Roger E.
    Bigner, Darell D.
    Yan, Hai
    CANCER RESEARCH, 2013, 73 (02) : 496 - 501
  • [4] Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
    van Noorden, Cornelis J. F.
    Hira, Vashendriya V. V.
    van Dijck, Amber J.
    Novak, Metka
    Breznik, Barbara
    Molenaar, Remco J.
    CELLS, 2021, 10 (03) : 1 - 16
  • [5] The Preclinical Efficacy Of Ketogenic Diet In IDH1 Wild-type And Mutant Gliomas
    Javier, Rodrigo
    Mirkov, Snezana
    Horbinski, Craig
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06): : 667 - 667
  • [6] RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer
    Zarei, Mahsa
    Lal, Shruti
    Vaziri-Gohar, Ali
    O'Hayer, Kevin
    Gunda, Venugopal
    Singh, Pankaj K.
    Brody, Jonathan R.
    Winter, Jordan M.
    MOLECULAR CANCER RESEARCH, 2019, 17 (02) : 508 - 520
  • [7] CHARACTERIZATION OF DIFFERENTIAL 5-HYDROXYMETHYLCYTOSINE IN IDH1 MUTANT VERSUS IDH1 WILD-TYPE HIGH-GRADE GLIOMAS
    Glowacka, Wioletta
    Jain, Harshika
    Okura, Makiko
    Maimaitiming, Abulizi
    Yasin, Mamatjan
    Farooq, Hamza
    Aldape, Kenneth
    Kongkham, Paul
    NEURO-ONCOLOGY, 2017, 19 : 95 - 95
  • [8] Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
    Christian Hartmann
    Bettina Hentschel
    Wolfgang Wick
    David Capper
    Jörg Felsberg
    Matthias Simon
    Manfred Westphal
    Gabriele Schackert
    Richard Meyermann
    Torsten Pietsch
    Guido Reifenberger
    Michael Weller
    Markus Loeffler
    Andreas von Deimling
    Acta Neuropathologica, 2010, 120 : 707 - 718
  • [9] Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
    Hartmann, Christian
    Hentschel, Bettina
    Wick, Wolfgang
    Capper, David
    Felsberg, Joerg
    Simon, Matthias
    Westphal, Manfred
    Schackert, Gabriele
    Meyermann, Richard
    Pietsch, Torsten
    Reifenberger, Guido
    Weller, Michael
    Loeffler, Markus
    von Deimling, Andreas
    ACTA NEUROPATHOLOGICA, 2010, 120 (06) : 707 - 718
  • [10] Wild-type IDH1: A molecular target in IDH1 mutant cancers
    Wickenden, Julie A.
    Russell, Paul
    Smith, Amy
    Henley, Tom
    Elliott, Jane
    Gitterman, Dan
    Stockdale, Mark
    Schofield, Christine
    Torrance, Chris
    Moore, Jonathan D.
    CANCER RESEARCH, 2014, 74 (19)